Skip to main content

Compare Stocks

Date Range: 

 TeleflexNovoCureInsuletAbiomedFresenius SE & Co. KGaA
SymbolNYSE:TFXNASDAQ:NVCRNASDAQ:PODDNASDAQ:ABMDOTCMKTS:FSNUY
Price Information
Current Price$393.00$179.27$232.42$268.56$13.73
52 Week RangeBuyHoldHoldHoldBuy
MarketRank™
Overall Score2.01.61.61.81.4
Analysis Score2.62.23.23.10.0
Community Score2.32.52.72.62.3
Dividend Score1.70.00.00.01.7
Ownership Score1.71.70.01.70.0
Earnings & Valuation Score1.91.91.91.93.1
Analyst Ratings
Consensus RecommendationBuyHoldHoldHoldBuy
Consensus Price Target$460.44$195.71$263.85$348.33N/A
% Upside from Price Target17.16% upside9.17% upside13.52% upside29.70% upsideN/A
Trade Information
Market Cap$18.32 billion$17.89 billion$14.98 billion$11.88 billion$29.69 billion
Beta1.141.290.761.411.36
Average Volume204,936950,268507,876314,63531,148
Sales & Book Value
Annual Revenue$2.60 billion$351.32 million$738.20 million$840.88 million$39.66 billion
Price / Sales7.0852.7720.8714.450.77
Cashflow$15.87 per shareN/A$0.55 per share$4.30 per share$2.54 per share
Price / Cash24.77N/A423.2062.525.40
Book Value$64.35 per share$2.20 per share$1.23 per share$23.64 per share$13.38 per share
Price / Book6.1181.49188.9611.361.03
Profitability
Net Income$461.47 million$-7,230,000.00$11.60 million$203.01 million$2.11 billion
EPS$11.15($0.07)$0.19$4.74$0.94
Trailing P/E Ratio50.58943.58528.2459.0215.09
Forward P/E Ratio31.14416.91211.2955.1513.20
P/E Growth2.63N/AN/A4.15N/A
Net Margins14.66%4.26%3.33%25.89%4.99%
Return on Equity (ROE)16.33%7.40%8.94%15.34%6.74%
Return on Assets (ROA)7.66%3.94%2.07%13.51%2.63%
Dividend
Annual Payout$1.36N/AN/AN/A$0.17
Dividend Yield0.35%N/AN/AN/A1.24%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio12.20%N/AN/AN/A18.09%
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.63%N/A1.55%N/A0.68%
Current Ratio2.99%4.02%6.62%6.81%1.21%
Quick Ratio1.88%3.74%5.91%6.02%0.92%
Ownership Information
Institutional Ownership Percentage89.78%71.09%N/A93.95%0.06%
Insider Ownership Percentage2.21%5.07%1.10%3.40%N/A
Miscellaneous
Employees14,0001,0231,9001,536311,269
Shares Outstanding46.73 million103.41 million66.27 million45.23 million2.23 billion
Next Earnings Date7/29/2021 (Estimated)7/29/2021 (Estimated)8/5/2021 (Estimated)8/5/2021 (Estimated)7/29/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable
SourceHeadline
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Hits New 52-Week High at $13.42Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Hits New 52-Week High at $13.42
americanbankingnews.com - May 13 at 7:48 PM
DZ Bank Reaffirms Buy Rating for Fresenius SE & Co. KGaA (OTCMKTS:FSNUY)DZ Bank Reaffirms Buy Rating for Fresenius SE & Co. KGaA (OTCMKTS:FSNUY)
americanbankingnews.com - May 12 at 12:10 PM
Germany stocks mixed at close of trade; DAX up 0.02%Germany stocks mixed at close of trade; DAX up 0.02%
investing.com - May 10 at 2:50 PM
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Announces Quarterly  Earnings ResultsFresenius SE & Co. KGaA (OTCMKTS:FSNUY) Announces Quarterly Earnings Results
americanbankingnews.com - May 7 at 2:57 PM
Fresenius Q1 Net Income Before Special Items Declines; Confirms FY21 GuidanceFresenius Q1 Net Income Before Special Items Declines; Confirms FY21 Guidance
nasdaq.com - May 6 at 2:30 AM
Fresenius-Aktie: Dritter Tag mit Gewinnen - Dax kann Fresenius nicht davonziehenFresenius-Aktie: Dritter Tag mit Gewinnen - Dax kann Fresenius nicht davonziehen
welt.de - May 5 at 11:16 AM
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Given Average Rating of "Buy" by BrokeragesFresenius SE & Co. KGaA (OTCMKTS:FSNUY) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - May 5 at 6:40 AM
Fresenius SE & Co. KGaA buy KirusFresenius SE & Co. KGaA buy Kirus
sharewise.com - May 4 at 5:45 PM
Fresenius-Aktie: Sechster Tag ohne Veränderung - Dax und Fresenius auf einer LinieFresenius-Aktie: Sechster Tag ohne Veränderung - Dax und Fresenius auf einer Linie
welt.de - May 3 at 11:42 AM
Fresenius-Aktie: Kurs erholt sich - Fresenius läuft besser als DaxFresenius-Aktie: Kurs erholt sich - Fresenius läuft besser als Dax
welt.de - May 1 at 4:22 PM
Germany stocks mixed at close of trade; DAX down 0.12%Germany stocks mixed at close of trade; DAX down 0.12%
investing.com - April 30 at 12:53 PM
Barclays senkt Ziel für Fresenius SE auf 50 Euro - OverweightBarclays senkt Ziel für Fresenius SE auf 50 Euro - 'Overweight'
t-online.de - April 29 at 10:10 AM
Fresenius SE-Aktie aktuell: Fresenius SE mit grünen VorzeichenFresenius SE-Aktie aktuell: Fresenius SE mit grünen Vorzeichen
finanzen.net - April 29 at 10:10 AM
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest UpdateFresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Update
americanbankingnews.com - April 28 at 7:10 PM
Fresenius SE & Co. KGaAs (FSNUY) Overweight Rating Reiterated at BarclaysFresenius SE & Co. KGaA's (FSNUY) Overweight Rating Reiterated at Barclays
americanbankingnews.com - April 28 at 5:32 PM
Fresenius-Aktie: Gleichbleibend - Fresenius kann mit Dax nicht mithaltenFresenius-Aktie: Gleichbleibend - Fresenius kann mit Dax nicht mithalten
welt.de - April 16 at 7:27 PM
Total Fluid Management Market Size 2021 Research Report including Industry Segment by Type, Historical Data and Market Forecast to 2026 - MarketWatchTotal Fluid Management Market Size 2021 Research Report including Industry Segment by Type, Historical Data and Market Forecast to 2026 - MarketWatch
marketwatch.com - April 16 at 2:26 PM
Fresenius-Aktie: Ohne Veränderung - Fast Gleichstand bei Dax und FreseniusFresenius-Aktie: Ohne Veränderung - Fast Gleichstand bei Dax und Fresenius
welt.de - April 15 at 10:45 AM
Fresenius-Aktie: Es geht wieder bergab - Fresenius kann mit Dax nicht mithaltenFresenius-Aktie: Es geht wieder bergab - Fresenius kann mit Dax nicht mithalten
welt.de - April 15 at 10:45 AM
Fresenius SE-Aktie aktuell: Fresenius SE präsentiert sich stärkerFresenius SE-Aktie aktuell: Fresenius SE präsentiert sich stärker
finanzen.net - April 11 at 2:34 PM
Fresenius-Aktie: Unternehmen erholt sich - Dax hinter Fresenius zurückFresenius-Aktie: Unternehmen erholt sich - Dax hinter Fresenius zurück
welt.de - April 9 at 5:53 PM
Germany stocks higher at close of trade; DAX up 0.21%Germany stocks higher at close of trade; DAX up 0.21%
investing.com - April 9 at 12:52 PM
Fitch Affirms Fresenius SE at BBB-; Outlook StableFitch Affirms Fresenius SE at 'BBB-'; Outlook Stable
fitchratings.com - April 6 at 7:31 PM
Fresenius SE KGaA Stock Is Believed To Be Modestly UndervaluedFresenius SE KGaA Stock Is Believed To Be Modestly Undervalued
gurufocus.com - April 1 at 1:46 PM
Fresenius-Aktie: Gleichbleibend - Fast Gleichstand bei Dax und FreseniusFresenius-Aktie: Gleichbleibend - Fast Gleichstand bei Dax und Fresenius
welt.de - March 23 at 12:54 PM
DateCompanyBrokerageAction
5/6/2021TeleflexMorgan StanleyBoost Price Target
5/6/2021TeleflexSVB LeerinkBoost Price Target
3/18/2021TeleflexRaymond JamesBoost Price Target
2/25/2021TeleflexPiper SandlerReiterated Rating
1/27/2021TeleflexJMP SecuritiesBoost Price Target
1/11/2021TeleflexWells Fargo & CompanyBoost Price Target
1/8/2021TeleflexKeyCorpBoost Price Target
1/6/2021TeleflexNeedham & Company LLCBoost Price Target
12/15/2020TeleflexUBS GroupBoost Price Target
4/26/2021NovoCureTruist SecuritiesBoost Price Target
4/20/2021NovoCureWedbushReiterated Rating
4/20/2021NovoCureMizuhoBoost Price Target
4/20/2021NovoCureNorthland SecuritiesBoost Price Target
8/3/2020NovoCureSunTrust BanksReiterated Rating
7/30/2020NovoCureOppenheimerReiterated Rating
5/7/2021InsuletBTIG ResearchReiterated Rating
3/25/2021InsuletCanaccord GenuityUpgrade
12/16/2020InsuletSmith Barney CitigroupDowngrade
12/16/2020InsuletCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellDowngrade
7/13/2020AbiomedOTR GlobalUpgrade
3/23/2020AbiomedStephensLower Price Target
9/30/2019AbiomedWilliam BlairReiterated Rating
8/2/2019AbiomedGuggenheimDowngrade
5/12/2021Fresenius SE & Co. KGaADZ BankReiterated Rating
4/28/2021Fresenius SE & Co. KGaABarclaysReiterated Rating
2/19/2021Fresenius SE & Co. KGaABerenberg BankReiterated Rating
2/10/2021Fresenius SE & Co. KGaAJPMorgan Chase & Co.Reiterated Rating
2/4/2021Fresenius SE & Co. KGaADeutsche Bank AktiengesellschaftDowngrade
1/6/2021Fresenius SE & Co. KGaANord/LBReiterated Rating
12/3/2020Fresenius SE & Co. KGaABank of AmericaDowngrade
8/5/2020Fresenius SE & Co. KGaAJefferies Financial GroupDowngrade
3/24/2020Fresenius SE & Co. KGaASanford C. BernsteinUpgrade
3/22/2019Fresenius SE & Co. KGaAThe Goldman Sachs GroupReiterated Rating
(Data available from 5/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.